Drug Industry Antitrust Act, 87-1&2U.S. Government Printing Office, 1961 Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs. |
From inside the book
Results 1-5 of 100
Page 1200
... patent protection of drugs and chemicals in certain foreign countries . It has been indicated that patents are issued in the United States for new chemical products and also for medicinal compositions . In this respect our law differs ...
... patent protection of drugs and chemicals in certain foreign countries . It has been indicated that patents are issued in the United States for new chemical products and also for medicinal compositions . In this respect our law differs ...
Page 1202
... protection by patents of new chemical products , independently of their ... patent law . The draft of a common law for the four countries , produced by ... patent law with a single patent to cover all six countries . The proposal has not ...
... protection by patents of new chemical products , independently of their ... patent law . The draft of a common law for the four countries , produced by ... patent law with a single patent to cover all six countries . The proposal has not ...
Page 1203
... patent , and I intend to comment on a few of these . DISCLOSURE OF THE INVENTION The application for patent must be ... Protection des In- ventions aux Etats - Unis , " Paris , 1961 , p . 36. ) Discounting a little the exuberance of the ...
... patent , and I intend to comment on a few of these . DISCLOSURE OF THE INVENTION The application for patent must be ... Protection des In- ventions aux Etats - Unis , " Paris , 1961 , p . 36. ) Discounting a little the exuberance of the ...
Page 1230
... patent protection , then the chart as given here is accurate . If the distinction . which I have made , however , is the correct one , that the distinction is between protection and no protection rather than product patents and no product ...
... patent protection , then the chart as given here is accurate . If the distinction . which I have made , however , is the correct one , that the distinction is between protection and no protection rather than product patents and no product ...
Page 1231
... Patent Protection on Drug Products . Table 35 : Comparison of Average Prices in Countries Without and With Patent Protection in Drug Products . And it does not say a hoot about the protection they get through the process . Those tables ...
... Patent Protection on Drug Products . Table 35 : Comparison of Average Prices in Countries Without and With Patent Protection in Drug Products . And it does not say a hoot about the protection they get through the process . Those tables ...
Other editions - View all
Common terms and phrases
advertising agreement amendments American antibiotics antitrust Appeals Association bill carbamate Chairman chemical chlorothiazide CHUMBRIS CIBA claims committee competition compounds compulsory licensing Corp cost countries court determine dicarbamate disclosure drug application drug companies drug industry drug manufacturers drug patents effective date Estes Kefauver examiner example fact FEDERICO field filed Food and Drug grant hospitals Hydrochlorothiazide infringement interference invention inventor issued JACKSON LADD legislation MACHLUP medicine ment meprobamate MERCK milligrams monopoly parties patent application patent laws Patent Office patent owner patent protection patent rights patent system percent Pfizer pharmaceutical physicians piperazine potassium carbonate prescribed present prior art problem product patents profits proposed provisions question royalty Secretary of Health Senator HRUSKA Senator KEFAUVER settlement Sherman Act specific SQUIBB statement Subcommittee tablets tests tion trade trademark TURNER U.S. Senate United USPQ utility VAGENIUS Welfare
Popular passages
Page 1736 - The specification shall contain a written description of the invention, and of the manner and process of making and using it. in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Page 1540 - I enter, I will go into them for the benefit of the sick, and will abstain from every voluntary act of mischief and corruption; and, further, from the seduction of females or males, of freemen and slaves.
Page 1556 - In the language of the statute, any person who "invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent," subject to the conditions and requirements of the law.
Page 1900 - A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102 of this title, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains.
Page 1592 - ... not known or used by others in this country before his invention or discovery thereof, and not patented or described in any printed publication in this or any foreign country before his invention or discovery thereof...
Page 1690 - No advertisement of a drug shall be deemed to be false if it is disseminated only to members of the medical profession, contains no false representation of a material fact, and includes, or is accompanied in each instance by truthful disclosure of, the formula showing quantitatively each ingredient of such drug.
Page 1782 - This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.
Page 1574 - ... full statement of the composition of such drug; (4) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug; (5) such samples of such drug and of the articles used as components thereof as the Secretary may require; and (6) specimens of the labeling proposed to be used for such drug.
Page 1802 - This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their successors and assigns.
Page 1976 - All disputes arising in connection with the present contract shall be finally settled under the rules of conciliation and arbitration of the International Chamber of Commerce by one or more arbitrators appointed in accordance with the rule".